Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Nirav Bhansali, CEO of Prism Jewellery, said the lab-grown diamond segment benefits from a dual advantage, with ...

Oct 23 (Reuters) - Dr. Lal PathLabs (DLPA.NS), opens new tab, India's top diagnostics firm by revenue, reported a bigger-than-expected second-quarter profit on Wednesday, driven by continued demand ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

In September, the US Department of Health and Human Services Office of Inspector General (OIG) issued an unfavorable advisory opinion to a pathology laboratory concerning a proposed services ...

Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multilayered deal with PathAI—acquiring some assets and licensing out others. The testing ...

MUMBAI, India--(BUSINESS WIRE)--Intertek, a Total Quality Assurance provider to industries worldwide, is pleased to announce that Acucert, its cybersecurity testing lab in Mumbai, has successfully ...

The partnership marks Cardio Diagnostics' first expansion outside the US and is focused on integrating the test within Dr. Lal PathLabs' laboratory and clinical network.